For the study, 98 patients scheduled for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery completed screening for depression. Twenty-eight percent of patients had scores indicating significant depression. After adjusting for pre-operative demographics and disease-specific factors, patients with symptoms indicating depression were more than five times more likely to incur complications or hospital readmission within 30 days.
The study warrants further research into the viability of pre-operative strategies to treat depressive symptoms, according to study authors. The researchers do not yet know if the data applies to patients undergoing less complex surgeries for different cancers.
More articles on quality:
Five ways to improve patient satisfaction surveys
VA leads the way in antibiotic stewardship efforts: 5 things to know
Patients and providers don’t see eye-to-eye on patient experience: 6 survey findings
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.